Dr. Chatterjee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
FDA White Oak Campus
Silver Spring, MD 20903
Summary
- Dr. Soumya Chatterjee is a Medical Officer specializing in Internal Medicine and Infectious Disease, currently serving at the FDA, Center for Biologics Evaluation and Research. He completed his Respiratory Medicine fellowship at the National Institutes of Health Clinical Center in 2013 and his Internal Medicine residency at the Icahn School of Medicine at Mount Sinai (North General) in 2009. Dr. Chatterjee is a proven scholar with publications in the Journal of Immunology and The American Journal of Gastroenterology, which have been cited numerous times.
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2013
Icahn School of Medicine at Mount Sinai (North General)Residency, Internal Medicine, 2009
RG Kar Medical College CalcuttaClass of 2004
Certifications & Licensure
TX State Medical License 2021 - 2026
PA State Medical License 2009 - 2022
MO State Medical License 2015 - 2020- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 142 citationsThe degree of breath methane production in IBS correlates with the severity of constipation.Soumya Chatterjee, Sandy Park, Kimberly Low, Yuthana Kong, Mark Pimentel
The American Journal of Gastroenterology. 2007-04-01 - 24 citationsHelminth-induced immune regulation: implications for immune responses to tuberculosis.Soumya Chatterjee, Thomas B. Nutman
Plos Pathogens. 2015-01-29 - 20 citationsHepatitis C Virus E2 Envelope Glycoprotein Induces an Immunoregulatory Phenotype in Macrophages.Young-Chan Kwon, Keith Meyer, Guangyong Peng, Soumya Chatterjee, Daniel F. Hoft
Hepatology. 2019-05-01
Press Mentions
With a Focus on High-Risk Patients, SLU Researcher Eyes Eliminating TB for GoodDecember 18th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
